ClinicalTrials.gg
Drug

Doxorubicin clinical trials

Also written Adriamycin, Rubex, Adriablastin and NSC-123127.

Includes 210 studies of Liposomal doxorubicin.

studies test it
779
open now
79
in phase 3
148
first study started
1990
Related medicines add 1 study

Counted the way a researcher would: Doxorubicin with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Doxorubicin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Doxorubicin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Aug 1974 · DOXORUBICIN HYDROCHLORIDE · NDA 050467 (FDA, Drugs@FDA)
European Union
20 Jun 1996 · Caelyx pegylated liposomal · EMEA/H/C/000089 (EMA; as liposomal doxorubicin)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Doxorubicin
249
doxorubicin hydrochloride
202
Adriamycin PFS
35
Adriamycin RDF
34
ADR
27

Brand

Adriamycin
130
Rubex
23
Doxil
6
Myocet
6
Caelyx
1

Development codes

NSC-123127
5

Other names

Adriablastin
22
hydroxydaunorubicin
7
Hydroxydaunomycin hydrochloride
5

In one entry with another drug

Given together, or one or the other

CHOP
15
ABVD
6
doxorubicin and cisplatin
2
Adriamycin/Cytoxan
2

Studies by the year they started

768 studies that test it; most in 2008 (48)

Studies that test Doxorubicin, by start year
YearStudies
19901
19924
19932
19947
19957
19969
199716
199820
199920
200024
200123
200225
200333
200445
200535
200644
200739
200848
200938
201025
201117
201225
201325
201415
201524
201629
201721
201818
201931
202012
202114
202215
202318
20248
202516
202615

By phase

A phase 1/2 study counts in both.

Early Phase 1
7
Phase 1
158
Phase 2
482
Phase 3
148
Phase 4
22
No phase
33

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 102 · Other 677

National Cancer Institute (NCI) (45) · M.D. Anderson Cancer Center (40) · Children's Oncology Group (28) · Memorial Sloan Kettering Cancer Center (20) · University of Washington (14) · St. Jude Children's Research Hospital (13) · European Organisation for Research and Treatment of Cancer - EORTC (11) · Alliance for Clinical Trials in Oncology (11)

Often tested with

Tested in the same studies.

Cyclophosphamide (271) · Vincristine (155) · Prednisone (105) · Etoposide (98) · Paclitaxel (86) · Cisplatin (80) · Dexamethasone (67) · Ifosfamide (67)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 42 phase 3 studies under way

Doxorubicin is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 36, 8 in phase 3

Studies that test Doxorubicin, phase 3 first.

Studies

Open first, then newest update. How each study uses Doxorubicin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 779

See all 779 studies that test Doxorubicin →

Given beside what is tested · 706 — Doxorubicin is usual care or a partner of the new treatment

Showing 20 of 706.

As the comparator · 129 — what is tested is compared with Doxorubicin

Showing 20 of 129.

Codes

What other systems call Doxorubicin · ClinicalTrials.gg INT007399

  • MeSH (NLM) D004317DoxorubicinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 80168379AGDOXORUBICINConfirmed FDA, NLM, Wikidata
  • RxNorm 3639Confirmed FDA, Wikidata
  • Wikidata Q18936doxorubicinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C456DoxorubicinOne source FDA
  • DrugBank DB00997One source Wikidata

Also registered as doxorubicin citrate (UNII AJQ2ZNG2WL) and doxorubicin hydrochloride (UNII 82F2G7BL4E · RxNorm 142433).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.